Lexapro and Cranberry extract drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lexapro (escitalopram oxalate) and Cranberry extract (cranberry). Common drug interactions include bronchitis among females and back pain among males.

The phase IV clinical study analyzes what interactions people have when they take Lexapro and Cranberry extract. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Lexapro?

Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 91,464 Lexapro users. Check the latest studies of Lexapro.

What is Cranberry extract?

Cranberry extract has active ingredients of cranberry. It is often used in urinary tract infection. eHealthMe is studying from 512 Cranberry extract users. Check the latest studies of Cranberry extract.



On Jul, 13, 2026

17 people who take Lexapro and Cranberry extract together, and have interactions are studied.

Lexapro and Cranberry extract drug interactions.

What are the common drug interactions of Lexapro and Cranberry Extract, by gender? *:

female:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  3. Headache (pain in head)
  4. Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
  5. Pruritus (severe itching of the skin)
  6. Renal cancer (cancer of kidney)
  7. Small intestinal obstruction (blockage in small intestine)
  8. Abdominal adhesions (inflammation of abdomen)
  9. Abdominal pain
  10. Arthralgia (joint pain)

male:

  1. Back pain
  2. Compression fracture (fracture due to pressure caused by injury)
  3. Neoplasm progression (growth of tumour)
  4. Pain in extremity
  5. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  6. Tumour pain
  7. Weight decreased
  8. Death
  9. Decreased appetite
  10. Drug ineffective

What are the common drug interactions of Lexapro and Cranberry Extract, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  2. Pulmonary embolism (blockage of the main artery of the lung)

20-29:

n/a

30-39:

n/a

40-49:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  3. Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
  4. Renal cancer (cancer of kidney)
  5. Small intestinal obstruction (blockage in small intestine)
  6. Abdominal adhesions (inflammation of abdomen)
  7. Haematemesis (vomiting of blood)
  8. Hypersensitivity
  9. Injection site urticaria (rash of round, red welts on the skin at injection site)
  10. Pruritus (severe itching of the skin)

50-59:

  1. Abdominal pain
  2. Blood pressure increased
  3. Breast cancer
  4. Dysgeusia (disorder of the sense of taste)
  5. Insomnia (sleeplessness)
  6. Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
  7. Pain
  8. Restlessness (not able to rest)
  9. Tongue discolouration (colour change of tongue)

60+:

  1. Headache (pain in head)
  2. Arthralgia (joint pain)
  3. Drug ineffective
  4. Facial pain
  5. Fall
  6. Fatigue (feeling of tiredness)
  7. Fear
  8. Gait disturbance
  9. General physical health deterioration (weak health status)
  10. Groin pain

What are the existing conditions these people have? *

  1. Asthma: 3 people, 17.65%
  2. Pain: 3 people, 17.65%
  3. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 17.65%
  4. High Blood Cholesterol: 3 people, 17.65%
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 11.76%
  6. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 11.76%
  7. Oedema (fluid collection in tissue): 2 people, 11.76%
  8. Nausea (feeling of having an urge to vomit): 2 people, 11.76%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.76%
  10. High Blood Pressure: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Lexapro and Cranberry extract?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lexapro and Cranberry extract:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lexapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cranberry extract:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lexapro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cranberry extract and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on escitalopram oxalate and cranberry (the active ingredients of Lexapro and Cranberry extract, respectively), and Lexapro and Cranberry extract (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: